3x Algocalmin, 500 mg, 20 film-coated tablets, Zentiva

Indications:
- Algocalmin contains metamizole sodium monohydrate, which is a painkiller (analgesic), belonging to the group of medicines known as pyrazolones. In addition to its analgesic effect, Algocalmin also has antispasmodic (anticonvulsant) and antipyretic (fever-reducing) effects;
- it is used to treat severe acute or persistent pain and high fever that does not respond to other treatments;
- this medicine is intended for adults and adolescents aged 15 years and over.

Contraindications:
Do not use Algocalmin:
- if you are allergic to metamizole or any of the other ingredients of this medicine.

Precautions:
Talk to your doctor or pharmacist before taking Algocalmin

Pregnancy, breast-feeding and fertility:
If you are pregnant or breast-feeding, think you may be pregnant or are planning to become pregnant, ask your doctor or pharmacist for advice before taking this medicine.

Pregnancy:
The available data on the use of metamizole during the first three months of pregnancy are limited, but do not indicate harmful effects on the embryo. In some cases, if there are no other treatment options, a single dose of metamizole may be acceptable during the first and second trimesters of pregnancy, after discussing with your doctor or pharmacist and after carefully weighing the benefits and risks of using metamizole. However, the use of metamizole during the first or second trimester is generally not recommended.

During the last three months of pregnancy, you should not take Algocalmin due to an increased risk of complications for both mother and child (bleeding, premature closure of an important blood vessel in the unborn child, called the ductus Botalli, which normally closes only after birth).
You should not use Algocalmin if you are in the first or last trimester of pregnancy, as it may harm the unborn child. In the second trimester of pregnancy, you can only use Algocalmin on the advice of your doctor, if he considers the treatment absolutely necessary, in the lowest possible dose and for the shortest possible period.

Breastfeeding:
The metabolism products of metamizole pass into breast milk in considerable quantities and a risk to the breastfed child cannot be excluded. Therefore, repeated administration of metamizole should be avoided in particular during breastfeeding. In the case of a single dose of metamizole, mothers are advised to collect and discard breast milk for 48 hours after administration.

Driving and using machines:
Administered in recommended doses, Algocalmin has no effects on the ability to drive or use machines. However, administered in high doses, Algocalmin may impair the ability to concentrate and react, which constitutes a risk of accidents, especially if associated with the consumption of ethyl alcohol.

If you notice that you experience balance disorders or a sensation of spinning objects after taking this medicine, avoid potentially dangerous activities, such as driving or using machines.

Method of administration:
Always use this medicine exactly as your doctor has told you. Talk to your doctor or pharmacist if you are not sure.

Swallow the tablets whole, preferably after meals.
The dose depends on the intensity of the pain or fever and the individual sensitivity to the response to Algocalmin.
The lowest dose necessary to control the pain and fever should always be chosen. Your doctor will tell you how to take Algocalmin.
Adults and children aged 15 years and over (weighing more than 53 kg):
The recommended dose is up to 1000 mg metamizole as a single dose (2 Algocalmin tablets).
If necessary, the dose can be repeated up to 4 times a day at intervals of 6-8 hours.
The maximum daily dose is 4000 mg (corresponding to 8 Algocalmin tablets).
A clear effect can be expected after 30 to 60 minutes after oral administration.

Children and adolescents under 15 years of age:
Algocalmin should not be used in children and adolescents under 15 years of age. For younger children, other pharmaceutical forms and strengths of this active substance are available; ask your doctor or pharmacist.

Patients with renal or hepatic impairment:
Since the elimination rate is reduced in patients with renal or hepatic impairment, repeated high doses should be avoided. No dose reduction is necessary when administered for only a short period of time. There is no experience with long-term use. Do not use Algocalmin for a long time.

Elderly and patients with poor health/renal insufficiency:
In elderly, patients with poor health and those with reduced kidney function, the dose should be reduced, as the elimination of metamizole metabolites may be delayed.

If you have any further questions on this medicine, ask your doctor or pharmacist.

Composition:
- The active substance is metamizole sodium monohydrate. Each tablet contains metamizole sodium monohydrate 500 mg.
- The other ingredients are: sugar, corn starch, magnesium stearate.

Presentation:
20 film-coated tablets

Algocalmin 500 mg 20 film-coated tablets Zentiva (metamizole sodium monohydrate) belongs to the drug group: analgesics antipyretics, contains the active substance: metamizole.